M. Coffiner

565 total citations
13 papers, 423 citations indexed

About

M. Coffiner is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, M. Coffiner has authored 13 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Neurology. Recurrent topics in M. Coffiner's work include Vitamin D Research Studies (4 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Cystic Fibrosis Research Advances (3 papers). M. Coffiner is often cited by papers focused on Vitamin D Research Studies (4 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Cystic Fibrosis Research Advances (3 papers). M. Coffiner collaborates with scholars based in Belgium, Canada and United States. M. Coffiner's co-authors include Francis Vanderbist, Ernst M. App, Pierrette Mäes, Hugues Malonne, Malcolm King, Maritta Orth, Adrian Gillissen, G. Schultze‐Werninghaus, André M. Cantin and Małgorzata Jaworska and has published in prestigious journals such as European Respiratory Journal, Nutrients and Osteoporosis International.

In The Last Decade

M. Coffiner

13 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Coffiner Belgium 10 109 99 98 71 64 13 423
Yuval Haskel Israel 13 50 0.5× 62 0.6× 126 1.3× 131 1.8× 100 1.6× 32 559
Edson Lopes Lavado Brazil 11 34 0.3× 48 0.5× 51 0.5× 26 0.4× 87 1.4× 24 465
Bojko Bjelaković Serbia 11 48 0.4× 27 0.3× 42 0.4× 42 0.6× 81 1.3× 56 482
Hermann Harder Germany 13 47 0.4× 59 0.6× 149 1.5× 61 0.9× 51 0.8× 28 516
Poonam Sharma India 12 40 0.4× 30 0.3× 47 0.5× 12 0.2× 79 1.2× 62 432
M. Schywalsky Germany 10 56 0.5× 14 0.1× 37 0.4× 79 1.1× 43 0.7× 22 440
Alex Griffiths United Kingdom 11 50 0.5× 117 1.2× 326 3.3× 76 1.1× 94 1.5× 29 623
Ziying Wu China 13 27 0.2× 61 0.6× 78 0.8× 53 0.7× 115 1.8× 45 537
Lü Ji China 11 36 0.3× 15 0.2× 142 1.4× 38 0.5× 98 1.5× 18 534
Marius Păpurică Romania 14 61 0.6× 32 0.3× 58 0.6× 65 0.9× 141 2.2× 54 559

Countries citing papers authored by M. Coffiner

Since Specialization
Citations

This map shows the geographic impact of M. Coffiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Coffiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Coffiner more than expected).

Fields of papers citing papers by M. Coffiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Coffiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Coffiner. The network helps show where M. Coffiner may publish in the future.

Co-authorship network of co-authors of M. Coffiner

This figure shows the co-authorship network connecting the top 25 collaborators of M. Coffiner. A scholar is included among the top collaborators of M. Coffiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Coffiner. M. Coffiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Coffiner, M., Anne‐Françoise Rousseau, Anne-Noëlle Frix, et al.. (2022). Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 14(15). 3048–3048. 52 indexed citations
2.
Coffiner, M., et al.. (2018). A Randomized Study to Compare a Monthly to a Daily Administration of Vitamin D3 Supplementation. Nutrients. 10(6). 659–659. 34 indexed citations
5.
Verbeeck, Roger K., et al.. (2015). The Lidose Hard Capsule Formulation of Fenofibrate is Suprabioavailable Compared to the Nanoparticle Tablet Formulation Under High-fat Fed Conditions. Journal of Pharmacy & Pharmaceutical Sciences. 18(1). 61–61. 4 indexed citations
6.
Peters, Triinu, et al.. (2006). TREATMENT OF ALCOHOLIC POLYNEUROPATHY WITH VITAMIN B COMPLEX: A RANDOMISED CONTROLLED TRIAL. Alcohol and Alcoholism. 41(6). 636–642. 31 indexed citations
7.
Malonne, Hugues, et al.. (2005). Long-term tolerability of tramadol LP, a new once-daily formulation, in patients with osteoarthritis or low back pain. Journal of Clinical Pharmacy and Therapeutics. 30(2). 113–120. 32 indexed citations
9.
App, Ernst M., Dana Baran, I. Dab, et al.. (2002). Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis. European Respiratory Journal. 19(2). 294–302. 44 indexed citations
10.
Gillissen, Adrian, Małgorzata Jaworska, Maritta Orth, et al.. (1997). Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro. Respiratory Medicine. 91(3). 159–168. 94 indexed citations
11.
Tomkiewicz, Robert P., Ernst M. App, George T. De Sanctis, et al.. (1995). A comparison of a new mucolytic N-acetylcysteine l-lysinate with N-acetylcysteine: Airway epithelial function and mucus changes in dog. Pulmonary Pharmacology. 8(6). 259–265. 28 indexed citations
12.
Coffiner, M., et al.. (1994). Mucolytic treatment with N-acetylcysteine L-lysinate metered dose inhaler in dogs: airway epithelial function changes. European Respiratory Journal. 7(1). 81–87. 19 indexed citations
13.
Hardy, J G, et al.. (1993). Lung Deposition of a Nacystelyn Metered Dose Inhaler Formulation. Journal of Aerosol Medicine. 6(1). 37–44. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026